Add time:07/19/2019         Source:sciencedirect.com

An efficient and scalable route for a series of novel substituted 2-anilino-7H-pyrrolopyrimidine compounds as potential inhibitors of PDK1, an important regulator of the PI3K/Akt pathway that is dysregulated in many cancers, was developed and is described. The synthetic strategy was designed around Suzuki and Buchwald–Hartwig cross-couplings of a boronate fragment and various customised anilines sequentially with 2,4-dichloro-7-tosyl-7H-pyrrolopyrimidine. All fragments were constructed separately and cross-coupled to provide access to a range of novel compounds. Biological evaluation of these was undertaken, with modest inhibition observed.

We also recommend Trading Suppliers and Manufacturers of 2-(1-Methyl-piperidin-3-ylMethoxy)-ethanol (cas 112391-02-3). Pls Click Website Link as below: cas 112391-02-3 suppliers